| |
 |
|
Class Information
Number: 424/9.2
Name: Drug, bio-affecting and body treating compositions > In vivo diagnosis or in vivo testing > Testing efficacy or toxicity of a compound or composition (e.g., drug, vaccine, etc.)
Description: Subject matter wherein the capacity of a compound or composition (e.g., drug, vaccine, etc.) to produce a desired effect or an injurious or harmful effect in a living subject is tested for.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7618624 |
Weight control using an anti-lipase antibody |
Nov. 17, 2009 |
| 7615207 |
Methods for treating irritable bowel syndrome |
Nov. 10, 2009 |
| 7615222 |
Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same |
Nov. 10, 2009 |
| 7611720 |
Tuberculosis vaccines including recombinant BCG strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase |
Nov. 3, 2009 |
| 7608277 |
Tuberculosis nucleic acids, polypeptides and immunogenic compositions |
Oct. 27, 2009 |
| 7608247 |
Use of outer membrane protein a in treatment/prevention/diagnosis of bacterial infection in central nervous system and/or peripheral blood circulation |
Oct. 27, 2009 |
| 7608246 |
Apolipoprotein E as an adjuvant for lipid antigens |
Oct. 27, 2009 |
| 7608245 |
Methods for manipulating satiety |
Oct. 27, 2009 |
| 7608278 |
Formulations of hydrophobic proteins in an immunogenic composition having improved tolerability |
Oct. 27, 2009 |
| 7604953 |
Bioamplification for microbial sensor signal transduction |
Oct. 20, 2009 |
| 7605248 |
Recombinant constructs of Borrelia burgdorferi |
Oct. 20, 2009 |
| 7601335 |
Pretreatment of a biological sample from an autoimmune disease subject |
Oct. 13, 2009 |
| 7601357 |
Targeting of long chain triacylglycerol hydrolase gene for tuberculosis treatment |
Oct. 13, 2009 |
| 7597891 |
Synthesis of human secretory IgA for the treatment of Clostridium difficile associated diseases |
Oct. 6, 2009 |
| 7597896 |
Composition comprising a protein encoded by a modified ERP gene of Mycobacterium |
Oct. 6, 2009 |
| 7595431 |
Mouse models of human prostate cancer |
Sep. 29, 2009 |
| 7592177 |
Compositions and methods for inducing cell dedifferentiation |
Sep. 22, 2009 |
| 7591997 |
Method for determining the susceptibility of a subject to infection |
Sep. 22, 2009 |
| 7582282 |
Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics |
Sep. 1, 2009 |
| 7579012 |
Targeting of triacylglycerol synthase gene for tuberculosis treatment |
Aug. 25, 2009 |
| 7579009 |
Whole bacterial cells as immune modulator |
Aug. 25, 2009 |
| 7579005 |
Process for recombinant expression and purification of antimicrobial peptides using periplasmic targeting signals as precipitable hydrophobic tags |
Aug. 25, 2009 |
| 7575877 |
Method of diagnosing tuberculosis |
Aug. 18, 2009 |
| 7572434 |
Method for assessing the effect of a drug on long term memory formation |
Aug. 11, 2009 |
| 7572457 |
Use of Streptococcus suis 38 kDa polypeptide as an immunogen |
Aug. 11, 2009 |
| 7572903 |
Method of regulation of bacterial persister status |
Aug. 11, 2009 |
| 7572455 |
Vaccine comprising an attenuated pestivirus |
Aug. 11, 2009 |
| 7572949 |
SKN-1 and GSK-3 genes and proteins |
Aug. 11, 2009 |
| 7569536 |
Method for controlling SR protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control SR protein activity |
Aug. 4, 2009 |
| 7569229 |
Monocyte locomotion inhibitory factor |
Aug. 4, 2009 |
| 7566459 |
Modified mycobacterium tuberculosis strains and uses thereof |
Jul. 28, 2009 |
| 7560229 |
Methods of use of the enzymes of mycothiol synthesis |
Jul. 14, 2009 |
| 7560096 |
Diagnostic procedures using direct injection of gaseous hyperpolarized .sup.129Xe and associated systems and products |
Jul. 14, 2009 |
| 7556810 |
Compositions and methods to control angiogenesis with cupredoxins |
Jul. 7, 2009 |
| 7553478 |
Methods for diagnosing and monitoring treatment ADHD by assessing the dopamine transporter level |
Jun. 30, 2009 |
| 7553616 |
Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
Jun. 30, 2009 |
| 7550260 |
Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
Jun. 23, 2009 |
| 7550258 |
Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
Jun. 23, 2009 |
| 7550150 |
Methods of treating or preventing a disease, disorder or condition associated with a viral infection |
Jun. 23, 2009 |
| 7547442 |
Newcastle disease virus infectious clones, vaccines and new diagnostic assays |
Jun. 16, 2009 |
| 7547506 |
Peptide-based fluorescence polarization assay for detection of antibodies to Mycobacterium bovis |
Jun. 16, 2009 |
| 7541447 |
Process for the preparation of an improved Brucella strain plasmid to develop the strain and the vaccine comprising the said strain |
Jun. 2, 2009 |
| 7538208 |
Type III secretion pathway in Aeromonas salmonicida, and uses therefor |
May. 26, 2009 |
| 7534437 |
Helminth-derived antigens having capacity of providing protection against parasites |
May. 19, 2009 |
| 7531164 |
Preventing bacterial or viral infectivity and composition containing infection preventing additive |
May. 12, 2009 |
| 7531183 |
Biologically active hemagglutinin from type A Clostridium botulinum and methods of use |
May. 12, 2009 |
| 7531500 |
Preventing airway mucus production by administration of EGF-R antagonists |
May. 12, 2009 |
| 7527973 |
Antibodies against West Nile Virus and therapeutic and prophylactic uses thereof |
May. 5, 2009 |
| 7527783 |
Methods for deactivating allergens and preventing disease |
May. 5, 2009 |
| 7521040 |
Immunotherapy for humans |
Apr. 21, 2009 |
|
|
|
